Keck School Faculty

Grace Marianne Facio
Grace Marianne Facio
Program Manager
Cancer Center
IRD 525 Health Sciences Campus Los Angeles

Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer Cancer Invest. 2012 May; 30(4):295-9. . View in PubMed

Phase I clinical trial of topotecan and pegylated liposomal doxorubicin Cancer Invest. 2005; 23(8):665-70. . View in PubMed

Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer Gynecol Oncol. 2004 May; 93(2):493-8. . View in PubMed

Powered by SC CTSI
Go to Top